Copyright Reports & Markets. All rights reserved.

Global Intravesical Immunotherapy Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Intravesical Immunotherapy Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Bacillus Calmette-Guerin (BCG) Therapy
    • 1.3.3 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Intravesical Immunotherapy Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospitals
    • 1.4.3 Clinics
  • 1.5 Global Intravesical Immunotherapy Market Size & Forecast
    • 1.5.1 Global Intravesical Immunotherapy Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Intravesical Immunotherapy Sales Quantity (2019-2030)
    • 1.5.3 Global Intravesical Immunotherapy Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Merck
    • 2.1.1 Merck Details
    • 2.1.2 Merck Major Business
    • 2.1.3 Merck Intravesical Immunotherapy Product and Services
    • 2.1.4 Merck Intravesical Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Merck Recent Developments/Updates
  • 2.2 Japan BCG Laboratory
    • 2.2.1 Japan BCG Laboratory Details
    • 2.2.2 Japan BCG Laboratory Major Business
    • 2.2.3 Japan BCG Laboratory Intravesical Immunotherapy Product and Services
    • 2.2.4 Japan BCG Laboratory Intravesical Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Japan BCG Laboratory Recent Developments/Updates
  • 2.3 China National Biotec
    • 2.3.1 China National Biotec Details
    • 2.3.2 China National Biotec Major Business
    • 2.3.3 China National Biotec Intravesical Immunotherapy Product and Services
    • 2.3.4 China National Biotec Intravesical Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 China National Biotec Recent Developments/Updates
  • 2.4 Serum Institute of India
    • 2.4.1 Serum Institute of India Details
    • 2.4.2 Serum Institute of India Major Business
    • 2.4.3 Serum Institute of India Intravesical Immunotherapy Product and Services
    • 2.4.4 Serum Institute of India Intravesical Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Serum Institute of India Recent Developments/Updates
  • 2.5 GSBPL
    • 2.5.1 GSBPL Details
    • 2.5.2 GSBPL Major Business
    • 2.5.3 GSBPL Intravesical Immunotherapy Product and Services
    • 2.5.4 GSBPL Intravesical Immunotherapy Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 GSBPL Recent Developments/Updates

3 Competitive Environment: Intravesical Immunotherapy by Manufacturer

  • 3.1 Global Intravesical Immunotherapy Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Intravesical Immunotherapy Revenue by Manufacturer (2019-2024)
  • 3.3 Global Intravesical Immunotherapy Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Intravesical Immunotherapy by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Intravesical Immunotherapy Manufacturer Market Share in 2023
    • 3.4.3 Top 6 Intravesical Immunotherapy Manufacturer Market Share in 2023
  • 3.5 Intravesical Immunotherapy Market: Overall Company Footprint Analysis
    • 3.5.1 Intravesical Immunotherapy Market: Region Footprint
    • 3.5.2 Intravesical Immunotherapy Market: Company Product Type Footprint
    • 3.5.3 Intravesical Immunotherapy Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Intravesical Immunotherapy Market Size by Region
    • 4.1.1 Global Intravesical Immunotherapy Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Intravesical Immunotherapy Consumption Value by Region (2019-2030)
    • 4.1.3 Global Intravesical Immunotherapy Average Price by Region (2019-2030)
  • 4.2 North America Intravesical Immunotherapy Consumption Value (2019-2030)
  • 4.3 Europe Intravesical Immunotherapy Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Intravesical Immunotherapy Consumption Value (2019-2030)
  • 4.5 South America Intravesical Immunotherapy Consumption Value (2019-2030)
  • 4.6 Middle East & Africa Intravesical Immunotherapy Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Intravesical Immunotherapy Sales Quantity by Type (2019-2030)
  • 5.2 Global Intravesical Immunotherapy Consumption Value by Type (2019-2030)
  • 5.3 Global Intravesical Immunotherapy Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Intravesical Immunotherapy Sales Quantity by Application (2019-2030)
  • 6.2 Global Intravesical Immunotherapy Consumption Value by Application (2019-2030)
  • 6.3 Global Intravesical Immunotherapy Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Intravesical Immunotherapy Sales Quantity by Type (2019-2030)
  • 7.2 North America Intravesical Immunotherapy Sales Quantity by Application (2019-2030)
  • 7.3 North America Intravesical Immunotherapy Market Size by Country
    • 7.3.1 North America Intravesical Immunotherapy Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Intravesical Immunotherapy Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Intravesical Immunotherapy Sales Quantity by Type (2019-2030)
  • 8.2 Europe Intravesical Immunotherapy Sales Quantity by Application (2019-2030)
  • 8.3 Europe Intravesical Immunotherapy Market Size by Country
    • 8.3.1 Europe Intravesical Immunotherapy Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Intravesical Immunotherapy Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Intravesical Immunotherapy Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Intravesical Immunotherapy Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Intravesical Immunotherapy Market Size by Region
    • 9.3.1 Asia-Pacific Intravesical Immunotherapy Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Intravesical Immunotherapy Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 South Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Intravesical Immunotherapy Sales Quantity by Type (2019-2030)
  • 10.2 South America Intravesical Immunotherapy Sales Quantity by Application (2019-2030)
  • 10.3 South America Intravesical Immunotherapy Market Size by Country
    • 10.3.1 South America Intravesical Immunotherapy Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Intravesical Immunotherapy Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Intravesical Immunotherapy Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Intravesical Immunotherapy Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Intravesical Immunotherapy Market Size by Country
    • 11.3.1 Middle East & Africa Intravesical Immunotherapy Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Intravesical Immunotherapy Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Intravesical Immunotherapy Market Drivers
  • 12.2 Intravesical Immunotherapy Market Restraints
  • 12.3 Intravesical Immunotherapy Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Intravesical Immunotherapy and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Intravesical Immunotherapy
  • 13.3 Intravesical Immunotherapy Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Intravesical Immunotherapy Typical Distributors
  • 14.3 Intravesical Immunotherapy Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Immunotherapy is a biologic therapy that activates the patient’s immune system and triggers a response to fight cancer. For bladder cancer, a common immunotherapy after surgery is Bacillus Calmette-Guerin (BCG) Therapy. During BCG therapy, a catheter is used to fill the patient's bladder with the drug and remains there for roughly two hours. BCG therapy stimulates an immune system response to attack and kill cancer cells. Newer innovative, more selective and targeted immunotherapy agents are currently being tested at a handful of centers worldwide, including the University of Chicago Medicine.
    According to our (Global Info Research) latest study, the global Intravesical Immunotherapy market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.
    This report is a detailed and comprehensive analysis for global Intravesical Immunotherapy market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
    Key Features:
    Global Intravesical Immunotherapy market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Intravesical Immunotherapy market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Intravesical Immunotherapy market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
    Global Intravesical Immunotherapy market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Intravesical Immunotherapy
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Intravesical Immunotherapy market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Japan BCG Laboratory, China National Biotec, Serum Institute of India, GSBPL, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Intravesical Immunotherapy market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Bacillus Calmette-Guerin (BCG) Therapy
    Others
    Market segment by Application
    Hospitals
    Clinics
    Major players covered
    Merck
    Japan BCG Laboratory
    China National Biotec
    Serum Institute of India
    GSBPL
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Intravesical Immunotherapy product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Intravesical Immunotherapy, with price, sales quantity, revenue, and global market share of Intravesical Immunotherapy from 2019 to 2024.
    Chapter 3, the Intravesical Immunotherapy competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Intravesical Immunotherapy breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Intravesical Immunotherapy market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Intravesical Immunotherapy.
    Chapter 14 and 15, to describe Intravesical Immunotherapy sales channel, distributors, customers, research findings and conclusion.

    Buy now